{
  "id": 19628108,
  "title": "Biomatter lands $18M to speed up enzyme development with AI",
  "url": "https://urgent.news/2026/11/12/biomatter-lands-18m-to-speed-up-enzyme-development-with-ai",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-12T08:51:47.000Z",
  "source": {
    "name": "Tech.eu",
    "slug": "tech-eu",
    "url": "https://tech.eu/2026/11/12/biomatter-lands-18m-to-speed-up-enzyme-development-with-ai/"
  },
  "original_language": "en",
  "account": "Biomatter, a firm specializing in the custom design of enzymes, has successfully secured $18 million in funding for its innovative use of AI in enzyme development. The oversubscribed Series A round was led by Astanor, with backing from existing investors UVC Partners, Inventure, and Metaplanet.\n\nThe company's approach to enzyme development is unique; they create enzymes based on the specific chemistry required for an industrial process, rather than modifying existing natural enzymes. This method has the potential to significantly reduce the time traditionally required for enzyme development, which can span months or even years.\n\nBiomatter leverages computational models and laboratory testing, using a proprietary dataset of experimentally characterized enzymes that grows with each development program. Their technology has already been utilized for enterprise customers across Europe, the United States, and Japan, including prominent names like AstraZeneca, BASF, Sanofi, and Tereos.\n\nThe funding will be used to establish a new 2,000-square-meter enzyme design and testing facility in Vilnius, slated to open in 2027. This facility aims to bring more development and testing activities in-house, thereby reducing enzyme development timelines from weeks to days. Additionally, Biomatter plans to expand its commercial team and presence in the United States, while continuing to refine its computational platform and proprietary enzyme dataset.",
  "summary": "Biomatter, a company specialising in customenzyme design, has raised $18 million in an oversubscribed Series A fundinground led by Astanor, with participation from existing investors UVC Partners,Inve...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}